. Author manuscript; available in PMC: 2006 Jul 13.

Published in final edited form as: J Proteome Res. 2006 Jul;5(7):1555–1567. doi: 10.1021/pr0504283

Table 1.

Description of animal models in the current study.

Phenotype	High-metastasis phenotype	Low-metastasis phenotype
Group	Control	Caffeine21	Caffeine60	DBA	NZB
Modification	None	Pharmacological	Pharmacological	Genetic variation	Genetic variation
Genetic background	FVB/NJ homozygous	FVB/NJ homozygous	FVB/NJ homozygous	DBA/2J × FVB/NJ	NZB/B1NJ × FVB/NJ
Transgene	PyMT	PyMT	PyMT	PyMT	PyMT
Treatment	None	Caffeine exposure starting from weaning to 100 days of age	Caffeine exposure starting from 60 days of age to 100 days of age	None	None